Calls
3
D.A. Wallach
Partner, Time BioVentures
Win Rate
100.0%
return
+13.4%
Loading charts...
Ticker
Side
Mentions
First Call
Call Price
P&L
Thesis
Theme
Source
Long
Feb 06
$16.55
+1.9%
Big Pharma is increasingly buying early-stage assets from China (30-40% of acquisitions vs. single digits previously). Clinical trials in China are significantly cheaper and faster. China has successfully built a biotech infrastructure that is now integrating into the global supply chain. As US/EU firms outsource early development to China for speed/cost, Chinese biotech firms become prime M&A targets or dominant players in early-stage discovery. LONG. This is a contrarian play on Chinese innovation capabilities rather than just consumer demand. Geopolitical tensions; regulatory changes regarding data acceptance (though currently improving); US restrictions on Chinese biotech.
Big Pharma is increasingly buying early-stage assets from China (30-40% of acquisitions vs. single digits previously). Clinical trials in China are significantly cheaper and faster. China has successfully built a biotech infrastructure that is now integrating into the global supply chain. As US/EU firms outsource early development to China for speed/cost, Chinese biotech firms become prime M&A targets or dominant players in early-stage discovery. LONG. This is a contrarian play on Chinese innovation capabilities rather than just consumer demand. Geopolitical tensions; regulatory changes regarding data acceptance (though currently improving); US restrictions on Chinese biotech.
Equity Indexes
Long
Feb 06
$91.24
+35.9%
Global balance sheets have expanded 5x over 60 years, largely driven by asset price inflation and corporate profits. Corporate profits are being structurally supported by government deficits (Govt borrows -> pays entitlements -> recipients spend at Corps). This cycle supports real assets and equities over cash. LONG. Real assets and equities are the hedge against the "deficit-profit" loop. Fiscal austerity (unlikely); major recession curbing consumer spending.
Global balance sheets have expanded 5x over 60 years, largely driven by asset price inflation and corporate profits. Corporate profits are being structurally supported by government deficits (Govt borrows -> pays entitlements -> recipients spend at Corps). This cycle supports real assets and equities over cash. LONG. Real assets and equities are the hedge against the "deficit-profit" loop. Fiscal austerity (unlikely); major recession curbing consumer spending.
Commodities
Long
Feb 06
$56.42
+2.5%
Global balance sheets have expanded 5x over 60 years, largely driven by asset price inflation and corporate profits. Corporate profits are being structurally supported by government deficits (Govt borrows -> pays entitlements -> recipients spend at Corps). This cycle supports real assets and equities over cash. LONG. Real assets and equities are the hedge against the "deficit-profit" loop. Fiscal austerity (unlikely); major recession curbing consumer spending.
Global balance sheets have expanded 5x over 60 years, largely driven by asset price inflation and corporate profits. Corporate profits are being structurally supported by government deficits (Govt borrows -> pays entitlements -> recipients spend at Corps). This cycle supports real assets and equities over cash. LONG. Real assets and equities are the hedge against the "deficit-profit" loop. Fiscal austerity (unlikely); major recession curbing consumer spending.
Thematic ETFs
Showing 3 of 3 calls · sorted by mentions
Choose a mentions count to open ticker posts.
D.A. Wallach has 3 trade ideas tracked on Buzzberg across 3 tickers since February 2026. Most covered: XLE, BNO, KURE.
